Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Urologic Surgery Outcomes
Urologic Surgery ACS NSQIP Outcomes
January 1, 2023 – December 31, 2023
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s urologic surgery ACS NSQIP performance benchmarked against 553 participating sites.
| Urologic Surgery (553 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 677 | 0.74% | 0.56% |
| 30 Day Morbidityᵃ | 677 | 7.68% | 10.53% |
| Cardiac | 677 | 1.18% | 0.78% |
| Pneumonia | 677 | 0.30% | 0.93% |
| Unplanned Intubation | 677 | 0.59% | 0.64% |
| Ventilator > 48 Hours | 676 | 0.44% | 0.43% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 677 | 2.22% | 1.39% |
| Renal Failure | 676 | 2.81% | 1.89% |
| Urinary Tract Infection (UTI)ᵃ | 677 | 1.03% | 2.73% |
| Surgical Site Infection (SSI)ᵃ | 677 | 1.92% | 4.05% |
| Sepsis | 676 | 1.63% | 2.37% |
| Unplanned Reoperation | 677 | 0.89% | 2.27% |
| Unplanned Readmission | 677 | 8.86% | 8.48% |
American College of Surgeons National Surgical Quality Improvement Program, 2024.
ACS NSQIP® Semiannual Report July 8, 2024, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.
